Loading...
Loading...
Spectrum Pharmaceuticals, Inc.
SPPI and Allos
Therapeutics, Inc.
ALTH today announced that the
offer period in connection with Spectrum's tender offer to purchase all
of the outstanding shares of common stock of Allos for $1.82 per share
in cash, without interest and less any applicable withholding taxes,
expired at 5:00 p.m., Eastern time, on September 4, 2012.
Based on information provided by the depository for the tender offer, a
total of 96,259,850 Shares were validly tendered and not withdrawn at
the Expiration (including 2,368,421 shares tendered pursuant to the
guaranteed delivery procedures set forth in the Offer to Purchase),
representing approximately 89.98% of the outstanding shares of Allos
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in